merck oral glp-1 receptor agonists: competition for efficacy and tolerability Merck & Co. signs license

Patients with cardiovascular contraindications to phentermine, or who cannot tolerate stimulant-based medications, may be candidates for orlistat as an alternative approach

No, GLP-1 receptor agonists are not approved for treating Hashimoto's thyroiditis and lack clinical evidence supporting their use for autoimmune thyroid disease

Many of our guests experiencing thinning are actually looking for something else: More fullness

Schools and childcare centers are serving more fruits, vegetables, and whole grains in their meals and snacks

Being denied coverage for a medication can be frustrating, but its vital to remember the importance of lifestyle changes like consistent exercise and a balanced diet